Image Credit: Momoneymoproblemz – CC BY-SA 4.0/Wiki Commons

Eli Lilly cuts Zepbound weight-loss vial prices on its DTC site

Eli Lilly is cutting what self-paying patients shell out for its blockbuster obesity drug Zepbound when they buy single-dose vials directly through its own online pharmacy. The move reshapes the cash market for GLP-1 weight-loss drugs, tightening pressure on rivals and testing how far manufacturers will go to answer political and public anger over sky-high…

Read More